Patient, Family & Staff Safety is our Priority: COVID-19 

Day: April 17, 2019

Posted in
Posted in

Spravato (Esketamine) for Treatment Resistant Depression – An FDA Approved “Breakthrough Therapy”

Last Updated on June 16, 2021 by Inspire Malibu In March 2019, the U.S. Food and Drug Administration (FDA) announced the approval of Spravato (Esketamine) for use in patients diagnosed with treatment-resistant depression. Spravato is a nasal spray that can only be administered by an approved health care provider, in the physician’s office or clinic, […]

CONTINUE READING Spravato (Esketamine) for Treatment Resistant Depression – An FDA Approved “Breakthrough Therapy” 7 min read
TOP
WELCOME TO INSPIRE MALIBU
PGlmcmFtZSB3aWR0aD0iODUzIiBoZWlnaHQ9IjQ4MCIgc3JjPSJodHRwczovL215Lm1hdHRlcnBvcnQuY29tL3Nob3cvP209ZHVlNkpBcWFtR1AiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+